President and CSO Stephen Connelly Sells $723K in Company Stock
EQ has more than doubled off its 52-week low of $0.27.
Summary
Equillium's President and CSO, Stephen Connelly, sold $723,830 worth of common stock in open market transactions, following a recent Form 144 filing and contributing to a trend of insider selling.
Key Events · Ownership and Investor Activity · EQ
-
Key Insider Sells Significant Stake
Stephen Connelly, President and CSO, sold 230,975 shares of common stock for a total value of $723,830 across two transactions on June 4-5, 2026.
-
Follows Intent to Sell Filing
This Form 4 filing finalizes the sale previously indicated by a Form 144 filed on June 4, 2026, where Connelly declared his intent to sell over $632,000 worth of stock.
-
Substantial Reduction in Holdings
The sale represents approximately 23% of Connelly's direct holdings prior to the transaction, leaving him with 762,025 shares post-sale.
-
Contributes to Insider Distribution Trend
This transaction adds to a net insider distribution of over $1.45 million in open-market sales over the past 90 days, with no reported open-market purchases.
Analysis · EQ · Life Sciences
Equillium's President and CSO, Stephen Connelly, executed a significant open-market sale of common stock totaling over $723,000. This transaction follows a Form 144 filing just yesterday, indicating his intent to sell, and represents a substantial reduction in his direct holdings. The sale contributes to a broader pattern of insider distribution at the company, with over $1.45 million in net insider sales over the last 90 days, which could be viewed negatively by investors, especially following recent capital raises and a reverse stock split approval.
At the time of this filing, EQ was trading at $2.94 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $185.9M. The 52-week trading range was $0.27 to $3.45. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.